Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies MPM BIOVENTURES 2018, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kush Parmar - $3.65M of TRDA open-market activity in the last 12 months
- 5AM Ventures V, L.P. - $3.00M of TRDA open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $1.61M of TRDA open-market activity in the last 12 months
- MPM BioVentures 2014, L.P. - $462K of TRDA open-market activity in the last 12 months
- Kory James Wentworth - $434K of TRDA open-market activity in the last 12 months
- Nathan J. Dowden - $426K of TRDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is MPM BIOVENTURES 2018, L.P.?
MPM BIOVENTURES 2018, L.P. is an investment firm, tracked as 10% Owner of Entrada Therapeutics, Inc. (TRDA). InsiderAlpha holds 3 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has MPM BIOVENTURES 2018, L.P. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has MPM BIOVENTURES 2018, L.P. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($20.03M) and 5 open-market sales ($1.38M) across all tracked filings.
Where can I see all of MPM BIOVENTURES 2018, L.P.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow MPM BIOVENTURES 2018, L.P. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
